Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Com...( LONDON March 3 /- Based on its recent...),Health

LONDON, March 3 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Aesku.Diagnostics with the 2008 European Frost & Sullivan Product Line Strategy Award for its consistent approach towards product development. It has anticipated and catered to the needs in bio-marker identification, offered versatile immunoassay systems, extended research capabilities as well as delivered unprecedented sensitivity and exceptional performance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

In just eight years of its existence, Aesku.Diagnostics has acquired several antigen and therapy patents and has become a recognised name in the autoimmune diagnostics market in more than 80 countries. It has earned a solid reputation in the market for launching over 140 different products, catering to autoimmune diagnostics and laying equal emphasis on all the major disease sectors under the autoimmune disease diagnostic space.

"Its products fall under two major brands namely, AESKULISA(R) {enzyme-linked immunosorbent assays (ELISA) kits} and AESKUSLIDES(R) (immunofluorescence slide panels)," says Frost & Sullivan Suraj Ramanathan. "The AESKU tests are developed based on human recombinant antigens or native antigens (conformational epitopes) depending on the optimal clinical correlation."

ELISA kits are more popular for autoimmune diagnosis; the company provides more than 100 CE marked kits incorporating human recombinant antigens synthesized in-house to assure maximum sensitivity and specificity. The kits can be used for diagnosing rheumatology, thrombosis, gastroenterology, vasculitis, thyroid, diabetes, hepatology and other rare autoimmune complications. While its 30-30-30 test format can be used with most commercially available automated test platf
'/>"/>